Literature DB >> 11757795

Use of atypical antipsychotics in mood disorders.

R Weizman1, A Weizman.   

Abstract

Cumulative data indicate that atypical antipsychotics can serve as adjunctive as well as alternative agents in the treatment of drug-resistant mood disorders. Olanzapine and risperidone add-on treatment was found to be effective for major depression with psychotic features and good results were achieved with currently available atypical antipsychotics (clozapine, risperidone, olanzapine, quetiapine and ziprasidone) in reducing symptoms of acute mania, especially when added to mood stabilizers. The role of atypical antipsychotics in maintenance and prophylactic treatment is not yet clear. Although there are differences in the side effect profiles of the various atypical antipsychotics, their use is limited by adverse effects such as extrapyramidal symptoms, weight gain, somnolence and sexual dysfunction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11757795

Source DB:  PubMed          Journal:  Curr Opin Investig Drugs        ISSN: 1472-4472


  4 in total

Review 1.  Comorbidity of depression and anxiety in the elderly.

Authors:  Eric J Lenze
Journal:  Curr Psychiatry Rep       Date:  2003-05       Impact factor: 5.285

2.  Low doses of clozapine may stabilize treatment-resistant bipolar patients.

Authors:  Bettina S Fehr; M Erkan Ozcan; Trisha Suppes
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-11-12       Impact factor: 5.270

Review 3.  Benefit-risk assessment of atypical antipsychotics in the treatment of schizophrenia and comorbid disorders in children and adolescents.

Authors:  Paz Toren; Sharon Ratner; Nathaniel Laor; Abraham Weizman
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

4.  Risperidone, quetiapine, and olanzapine adjunctive treatments in major depression with psychotic features: a comparative study.

Authors:  A Gabriel
Journal:  Neuropsychiatr Dis Treat       Date:  2013-04-12       Impact factor: 2.570

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.